Daventry Pharma Limited in Nuneaton, CV11 6QA

Description

Data updated on: 01-11-2023

Started with Reg No. 06089986 seventeen years ago, Daventry Pharma Limited is categorised as a Private Limited Company. The business actual office address is 89 Lutterworth Road, Nuneaton. This company's registered with SIC code 47730 meaning Dispensing chemist in specialised stores. The business latest filed accounts documents cover the period up to 2022-02-28 and the latest annual confirmation statement was filed on 2023-02-07.

Given this company's constant growth, it was vital to formally appoint new company leaders: Tolulope E. and Mohammed A. who have been working together since February 2007 to exercise independent judgement of this company. In order to provide support to the directors, this specific company has been utilizing the skills of Tolulope E. as a secretary since February 2007.

Tolulope E. is the individual who has control over this firm, owns 1/2 or less of company shares.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-02-28	2012-02-29	2013-02-28	2014-02-28	2015-02-27	2015-02-28	2016-02-29	2017-02-28	2018-02-28	2019-02-28	2020-02-28	2021-02-28	2022-02-28	2023-02-28
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	104 255	75 274

Balance Sheet
Cash Bank On Hand							112 471	135 184	167 344	143 743	203 872	359 993	221 980	112 282
Current Assets	238 991	263 914	191 340	197 400	189 324	189 324	287 535	320 199	368 393	397 227	365 261	567 952	374 407	434 172
Debtors	158 371	176 898	154 228	90 154	85 757	85 757	150 867	148 573	156 801	206 991	122 211	172 871	121 839	286 939
Net Assets Liabilities							147 681	195 947	243 038	257 144	294 800	422 452	540 509	645 271
Other Debtors							37 526	30 806	33 447	73 931	59 430	33 824	37 076	188 885
Property Plant Equipment							13 355	10 016	7 512	5 634	64 115	69 593	947 896	962 710
Total Inventories							24 197	36 442	44 248	46 493	39 178	35 088	30 588	34 951
Cash Bank In Hand	27 540	47 741	5 648	73 927	83 414	83 414	112 471
Net Assets Liabilities Including Pension Asset Liability	104 255	75 274	50 708	40 437	79 813	79 813	147 681
Stocks Inventory	53 080	39 275	31 465	33 319	20 153	20 153	24 197
Tangible Fixed Assets	20 057	15 251	11 013	7 201	3 709	3 709	13 355

Capital & Reserves
Called Up Share Capital	2	2	2	2	2	2	2
Profit Loss Account Reserve	104 253	75 272	50 706	40 435	79 811	79 811	147 679
Shareholder Funds	104 255	75 274

Other Financial Data
Accumulated Depreciation Impairment Property Plant Equipment							33 446	36 785	39 289	41 167	43 797	46 075	50 029	53 599
Additions Other Than Through Business Combinations Property Plant Equipment														18 384
Average Number Employees During Period							10	6	6	6	5	5	5	5
Bank Borrowings Overdrafts											800 296	832 508	766 007	708 102
Corporation Tax Payable							14 527	12 841	11 682			28 207	29 004	25 440
Creditors							152 904	134 204	132 867	145 717	800 296	832 508	766 007	708 102
Fixed Assets	20 057	15 251								5 634	946 372	951 850	1 247 896	1 262 710
Future Minimum Lease Payments Under Non-cancellable Operating Leases							6 868	6 868	6 868
Increase From Depreciation Charge For Year Property Plant Equipment								3 339	2 504	1 878	2 630	2 278	3 953	3 570
Investment Property											882 257	882 257	300 000	300 000
Investment Property Fair Value Model											882 257		300 000
Net Current Assets Liabilities	101 831	68 005	43 201	33 816	76 524	76 524	134 631	185 995	235 526	251 510	148 724	303 110	60 259	92 424
Other Creditors							9 810	822	3 330	2 854	16 602	41 416	32 238	26 791
Other Taxation Social Security Payable							170	34	11 689	3 752	14 330	28 207
Property Plant Equipment Gross Cost							46 801	46 801	46 801	46 801	107 912	115 668	997 925	1 016 309
Provisions For Liabilities Balance Sheet Subtotal							305	64					1 639	1 761
Total Assets Less Current Liabilities	121 888	83 256	54 214	41 017	80 233	80 233	147 986	196 011	243 038	257 144	1 095 096	1 254 960	1 308 155	1 355 134
Trade Creditors Trade Payables							128 397	120 507	117 848	139 111	105 002	116 712	178 514	224 277
Trade Debtors Trade Receivables							113 341	117 767	123 354	133 060	62 781	139 047	84 763	98 054
Additions Other Than Through Business Combinations Investment Property Fair Value Model											882 257
Total Additions Including From Business Combinations Property Plant Equipment											61 111	7 756
Accruals Deferred Income	1 418	2 643
Creditors Due After One Year Total Noncurrent Liabilities	14 678	6 902
Creditors Due Within One Year Total Current Liabilities	139 840	193 266
Prepayments Accrued Income Not Expressed Within Current Asset Sub-total	2 680	2 680
Provisions For Liabilities Charges	1 537	1 080	790	580	420	420	305
Tangible Fixed Assets Cost Or Valuation	35 601	35 601	35 601	35 601		35 601	46 801
Tangible Fixed Assets Depreciation	15 544	20 350	24 588	28 400		31 892	33 446
Tangible Fixed Assets Depreciation Charge For Period		4 806
Capital Employed		75 274	50 708	40 437	79 813	79 813	147 681
Creditors Due After One Year		6 902	2 716
Creditors Due Within One Year		195 909	148 139	163 584	112 800	112 800	152 904
Number Shares Allotted			2	2		2	2
Par Value Share			1	1		1	1
Share Capital Allotted Called Up Paid		2	2	2	2	2	2
Tangible Fixed Assets Additions							11 200
Tangible Fixed Assets Depreciation Charged In Period			4 238	3 812		3 492	1 554

Company staff

Tolulope E.

Role: Secretary

Appointed: 07 February 2007

Latest update: 10 January 2024

Tolulope E.

Role: Director

Appointed: 07 February 2007

Latest update: 10 January 2024

Mohammed A.

Role: Director

Appointed: 07 February 2007

Latest update: 10 January 2024

People with significant control

Tolulope E.

Notified on 7 February 2017

Nature of control:

1/2 or less of shares

Accounts Documents

Account next due date	30 November 2023
Account last made up date	28 February 2022
Confirmation statement next due date	21 February 2024
Confirmation statement last made up date	07 February 2023

Annual Accounts 28 November 2013
Start Date For Period Covered By Report	2012-03-01
End Date For Period Covered By Report	2013-02-28
Date Approval Accounts	28 November 2013
Annual Accounts
Start Date For Period Covered By Report	2013-03-01
Annual Accounts 15 September 2015
Start Date For Period Covered By Report	2014-03-01
End Date For Period Covered By Report	28 February 2015
Date Approval Accounts	15 September 2015
Annual Accounts 20 November 2016
Start Date For Period Covered By Report	2015-03-01
End Date For Period Covered By Report	29 February 2016
Date Approval Accounts	20 November 2016
Annual Accounts
Start Date For Period Covered By Report	2016-03-01
End Date For Period Covered By Report	28 February 2017
Annual Accounts
Start Date For Period Covered By Report	2017-03-01
End Date For Period Covered By Report	28 February 2018
Annual Accounts
Start Date For Period Covered By Report	01 March 2018
End Date For Period Covered By Report	28 February 2019
Annual Accounts
Start Date For Period Covered By Report	01 March 2019
End Date For Period Covered By Report	28 February 2020
Annual Accounts
Start Date For Period Covered By Report	29 February 2020
End Date For Period Covered By Report	28 February 2021
Annual Accounts
Start Date For Period Covered By Report	29 February 2020
End Date For Period Covered By Report	28 February 2021
Annual Accounts
Start Date For Period Covered By Report	29 February 2020
End Date For Period Covered By Report	28 February 2021
Annual Accounts 9 October 2014
End Date For Period Covered By Report	28 February 2014
Date Approval Accounts	9 October 2014

Daventry Pharma Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Tolulope E.

Tolulope E.

Mohammed A.

People with significant control

Tolulope E.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest Companies - by postcode